Skip to content

ADMA Biologics ADMA Treasury Stock, Value

Treasury Stock, Value at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Quest Diagnostics logo
Quest DiagnosticsDGX
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.01B-54.5%
Enterprise value$2.08B-52.5%
P/E12.2×-9.2×
P/S-5.7×

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockValue.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's treasury stock, value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's treasury stock, value?
ADMA Biologics (ADMA) reported treasury stock, value of $143.17M in Q1 2026.
What does treasury stock, value mean?
This represents the cost of common shares that the company has repurchased from the open market and holds in its treasury. Treasury stock reduces total shareholders' equity and is often used for employee stock compensation plans or to return capital to shareholders. It is recorded as a contra-equity account.